SCHEMBL25979871

SCHEMBL25979871

O=C(O)c1cc(I)cc(C(=O)O)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 5/20 0.46
AKR1C1 Q04828 5/20 0.46
AKR1C4 P17516 3/20 0.46
AKR1C3 P42330 3/20 0.46
TP53 P04637 1/20 0.44
TTR P02766 2/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 3/20 0.43
THRB P10828 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.43
ATIC P31939 1/20 0.43
PTPN1 P18031 3/20 0.42
PTPRC P08575 1/20 0.42
PTPN2 P17706 1/20 0.42
PTPRA P18433 1/20 0.42
PTPRB P23467 1/20 0.42
PTPRE P23469 1/20 0.42
PTPN6 P29350 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11302359 0.89 TTR (0.41) AKR1C2AKR1C1AKR1C4AKR1C3TP53
SCHEMBL8285522 0.88 SELL (0.46) AKR1C2AKR1C1AKR1C4AKR1C3TP53
SCHEMBL29396210 0.88 TTR (0.56) AKR1C2AKR1C1AKR1C4AKR1C3TP53
SCHEMBL425350 0.88 TTR (0.56) AKR1C2AKR1C1AKR1C4AKR1C3TP53
SCHEMBL23803707 0.86 TTR (0.54) AKR1C2AKR1C1AKR1C4AKR1C3TP53
SCHEMBL340511 0.86 TTR (0.54) AKR1C2AKR1C1AKR1C4AKR1C3TP53
Lithium SCHEMBL410866 0.86 TTR (0.54) AKR1C2AKR1C1AKR1C4AKR1C3TP53
SCHEMBL9398438 0.86 TTR (0.54) AKR1C2AKR1C1AKR1C4AKR1C3TP53
SCHEMBL9403722 0.86 TTR (0.54) AKR1C2AKR1C1AKR1C4AKR1C3TP53
Lithium SCHEMBL30311136 0.86 TTR (0.54) AKR1C2AKR1C1AKR1C4AKR1C3TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150197-A1 ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2023-08-10 WO disclosed